TGFA antibody
Quick Overview for TGFA antibody (ABIN7865750)
Target
See all TGFA AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- anti-TGF-alpha mouse monoclonal, 1E8-G6, purified
-
Purification
- affinity chromatography
-
Immunogen
- synthetic TGF-alpha 34-43 decapeptide linked carrier
-
Isotype
- IgM kappa
-
-
-
-
Application Notes
-
FACS_dilution: 0.5-1,0 μg/million cells in 0.1 ml
IHC-paraffin_dilution: 1:50-1:100 (1-2 μg/mL, microwave treatment in 10 mM citrate buffer pH 6.0 recommended)
WB_dilution: 1:50-1:100 (1-2 μg/mL)
IHC-frozen_dilution: 1:50-1:100 (1-2 μg/mL)
elisa_dilution: assay dependent
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100 μg/mL
-
Buffer
- PBS with 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- store at 2 - 8 °C
-
-
- TGFA (Transforming Growth Factor, alpha (TGFA))
-
Alternative Name
- TGF-alpha
-
Background
- 1E8-G6 reacts with TGF-alpha and shows no cross-reaction with EGF and the neuropeptide synenkephalin. 1E8-G6 is completely blocked by the peptide used for immunization. TGF-alpha (aa50) is a growth factor with 33 % homology to EGF, binds to EGFR, activates tyrosine phosphorylation of the receptor, and stimulates cell proliferation. It plays a role in tumor initiation by inducing the reversible transformed phenotype. In sections both cytoplasma and cell membranes are stained. Positive control: Jurkat or Ramos cells. testicular carcinoma, breast cancer.
-
Pathways
- NF-kappaB Signaling, RTK Signaling, EGFR Signaling Pathway
Target
-